D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$315M |
| 2 |
Exxon Mobil
XOM
|
+$312M |
| 3 |
Verizon
VZ
|
+$289M |
| 4 |
Procter & Gamble
PG
|
+$288M |
| 5 |
Pfizer
PFE
|
+$272M |
Top Sells
| 1 |
Tesla
TSLA
|
+$619M |
| 2 |
Biogen
BIIB
|
+$369M |
| 3 |
Amazon
AMZN
|
+$341M |
| 4 |
Netflix
NFLX
|
+$309M |
| 5 |
Emerson Electric
EMR
|
+$306M |
Sector Composition
| 1 | Technology | 23.54% |
| 2 | Healthcare | 14.5% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 9.56% |
| 5 | Communication Services | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
PACCAR
PCAR
$51.6B
| $21.9M | 0.03% |
537,396
+398,013
| +286% | +$16.2M |
|
427
State Street
STT
$31.7B
| $21.8M | 0.03% |
409,801
-657,663
| -62% | -$35M |
|
428
Xerox
XRX
$482M
| $21.8M | 0.03% |
1,151,105
+387,598
| +51% | +$7.34M |
|
|
QTS
429
DELISTED
QTS REALTY TRUST, INC.
QTS
| $21.8M | 0.03% |
375,775
+130,693
| +53% | +$7.58M |
|
430
General Dynamics
GD
$86.8B
| $21.6M | 0.03% |
163,477
+28,190
| +21% | +$3.73M |
|
431
nVent Electric
NVT
$14.9B
| $21.4M | 0.03% |
1,271,174
+82,935
| +7% | +$1.4M |
|
432
QuidelOrtho
QDEL
$1.93B
| $21.4M | 0.03% |
218,854
+41,568
| +23% | +$4.07M |
|
|
CPAAU
433
DELISTED
Conyers Park II Acquisition Corp. Unit
CPAAU
| $21.2M | 0.03% |
2,000,000
| – | – |
|
434
Axsome Therapeutics
AXSM
$6.45B
| $21.1M | 0.03% |
358,695
+275,232
| +330% | +$16.2M |
|
|
DHR.PRA
435
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $21M | 0.03% |
+20,000
| New | +$21M |
|
436
Curtiss-Wright
CW
$18.2B
| $20.8M | 0.03% |
225,438
-58,442
| -21% | -$5.4M |
|
437
Bread Financial
BFH
$3.06B
| $20.8M | 0.03% |
773,606
+93,978
| +14% | +$2.52M |
|
438
McCormick & Company Non-Voting
MKC
$18.8B
| $20.7M | 0.03% |
293,828
+290,650
| +9,146% | +$20.5M |
|
439
Archer Daniels Midland
ADM
$29.9B
| $20.7M | 0.03% |
588,525
+481,871
| +452% | +$17M |
|
440
Editas Medicine
EDIT
$251M
| $20.7M | 0.03% |
1,043,049
-365,947
| -26% | -$7.26M |
|
441
Martin Marietta Materials
MLM
$37.8B
| $20.7M | 0.03% |
109,214
+96,086
| +732% | +$18.2M |
|
442
Rambus
RMBS
$7.88B
| $20.6M | 0.03% |
1,852,433
-429,698
| -19% | -$4.77M |
|
443
PRA Group
PRAA
$672M
| $20.5M | 0.03% |
739,671
+148,513
| +25% | +$4.12M |
|
|
MDRX
444
DELISTED
Veradigm Inc. Common Stock
MDRX
| $20.4M | 0.03% |
2,899,810
-890,555
| -23% | -$6.27M |
|
|
XEC
445
DELISTED
CIMAREX ENERGY CO
XEC
| $20.4M | 0.03% |
1,211,180
+1,192,386
| +6,345% | +$20.1M |
|
446
Medpace
MEDP
$13.8B
| $20.4M | 0.03% |
277,772
+91,079
| +49% | +$6.68M |
|
447
Healthpeak Properties
DOC
$12.7B
| $20.3M | 0.03% |
852,718
+285,613
| +50% | +$6.81M |
|
448
Sonos
SONO
$1.78B
| $20.3M | 0.03% |
2,394,666
+155,066
| +7% | +$1.31M |
|
449
Sabre
SABR
$698M
| $20.1M | 0.03% |
3,387,377
+1,070,930
| +46% | +$6.35M |
|
450
Kirby Corp
KEX
$4.98B
| $20M | 0.03% |
460,935
-6,053
| -1% | -$263K |
|